247 related articles for article (PubMed ID: 26005508)
1. Therapeutic Angiogenesis by Gene Therapy for Critical Limb Ischemia: Choice of Biological Agent.
Sanada F; Taniyama Y; Azuma J; Yuka II; Kanbara Y; Iwabayashi M; Rakugi H; Morishita R
Immunol Endocr Metab Agents Med Chem; 2014 Apr; 14(1):32-39. PubMed ID: 26005508
[TBL] [Abstract][Full Text] [Related]
2. Gene therapy in peripheral artery disease.
Sanada F; Taniyama Y; Kanbara Y; Otsu R; Ikeda-Iwabu Y; Carracedo M; Rakugi H; Morishita R
Expert Opin Biol Ther; 2015 Mar; 15(3):381-90. PubMed ID: 25633211
[TBL] [Abstract][Full Text] [Related]
3. Endothelial progenitor cells in clinical settings.
Sanada S; Taniyama Y; Azuma J; Yuka II; Iwabayashi M; Rakugi H; Morishita R
J Stem Cells; 2014; 9(2):117-25. PubMed ID: 25158160
[TBL] [Abstract][Full Text] [Related]
4. Gene therapy for peripheral arterial disease.
Forster R; Liew A; Bhattacharya V; Shaw J; Stansby G
Cochrane Database Syst Rev; 2018 Oct; 10(10):CD012058. PubMed ID: 30380135
[TBL] [Abstract][Full Text] [Related]
5. Gene-Therapeutic Strategies Targeting Angiogenesis in Peripheral Artery Disease.
Sanada F; Taniyama Y; Muratsu J; Otsu R; Shimizu H; Rakugi H; Morishita R
Medicines (Basel); 2018 Mar; 5(2):. PubMed ID: 29601487
[TBL] [Abstract][Full Text] [Related]
6. Growth factors for angiogenesis in peripheral arterial disease.
Gorenoi V; Brehm MU; Koch A; Hagen A
Cochrane Database Syst Rev; 2017 Jun; 6(6):CD011741. PubMed ID: 28594443
[TBL] [Abstract][Full Text] [Related]
7. Combined Analysis of Clinical Data on HGF Gene Therapy to Treat Critical Limb Ischemia in Japan.
Morishita R; Shimamura M; Takeya Y; Nakagami H; Chujo M; Ishihama T; Yamada E; Rakugi H
Curr Gene Ther; 2020; 20(1):25-35. PubMed ID: 32416690
[TBL] [Abstract][Full Text] [Related]
8. Stenting for peripheral artery disease of the lower extremities: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2010; 10(18):1-88. PubMed ID: 23074395
[TBL] [Abstract][Full Text] [Related]
9. Gene therapy for peripheral arterial disease.
Shimamura M; Nakagami H; Taniyama Y; Morishita R
Expert Opin Biol Ther; 2014 Aug; 14(8):1175-84. PubMed ID: 24766232
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic angiogenesis for critical limb ischaemia.
Annex BH
Nat Rev Cardiol; 2013 Jul; 10(7):387-96. PubMed ID: 23670612
[TBL] [Abstract][Full Text] [Related]
11. Angiogenesis in peripheral arterial disease.
Inampudi C; Akintoye E; Ando T; Briasoulis A
Curr Opin Pharmacol; 2018 Apr; 39():60-67. PubMed ID: 29529399
[TBL] [Abstract][Full Text] [Related]
12. Hepatocyte growth factor stimulated angiogenesis without inflammation: differential actions between hepatocyte growth factor, vascular endothelial growth factor and basic fibroblast growth factor.
Kaga T; Kawano H; Sakaguchi M; Nakazawa T; Taniyama Y; Morishita R
Vascul Pharmacol; 2012 Aug; 57(1):3-9. PubMed ID: 22361334
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic angiogenesis using zinc oxide nanoflowers for the treatment of hind limb ischemia in a rat model.
Barui AK; Nethi SK; Basuthakur P; Jhelum P; Bollu VS; Reddy BR; Chakravarty S; Patra CR
Biomed Mater; 2021 Mar; 16(4):. PubMed ID: 33657534
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic angiogenesis for revascularization in peripheral artery disease.
Grochot-Przeczek A; Dulak J; Jozkowicz A
Gene; 2013 Aug; 525(2):220-8. PubMed ID: 23566831
[TBL] [Abstract][Full Text] [Related]
15. Vascular endothelial cell growth factor and fibroblast growth factor 2 expression in patients with critical limb ischemia.
Palmer-Kazen U; Wariaro D; Luo F; Wahlberg E
J Vasc Surg; 2004 Mar; 39(3):621-8. PubMed ID: 14981457
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic angiogenesis for critical limb ischemia: design of the hepatocyte growth factor therapeutic angiogenesis clinical trial.
Powell RJ; Dormandy J; Simons M; Morishita R; Annex BH
Vasc Med; 2004 May; 9(3):193-8. PubMed ID: 15675184
[TBL] [Abstract][Full Text] [Related]
17. Establishment of optimal exercise therapy using near-infrared spectroscopy monitoring of tissue muscle oxygenation after therapeutic angiogenesis for patients with critical limb ischemia: A multicenter, randomized, controlled trial.
Shoji K; Yanishi K; Shiraishi H; Yamabata S; Yukawa A; Teramukai S; Imai K; Ito-Ihara T; Tao M; Higashi Y; Ishigami T; Fukumoto Y; Kuwahara K; Matoba S
Contemp Clin Trials Commun; 2020 Mar; 17():100542. PubMed ID: 32072074
[TBL] [Abstract][Full Text] [Related]
18. Clinical Safety and Preliminary Efficacy of Plasmid pUDK-HGF Expressing Human Hepatocyte Growth Factor (HGF) in Patients with Critical Limb Ischemia.
Cui S; Guo L; Li X; Gu Y; Fu J; Dong L; Song H; Chen X; Lu Y; Hu C; Xiao F; Zhu D; Wu Z; Zhang Q
Eur J Vasc Endovasc Surg; 2015 Oct; 50(4):494-501. PubMed ID: 26122834
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic strategies for cell-based neovascularization in critical limb ischemia.
Samura M; Hosoyama T; Takeuchi Y; Ueno K; Morikage N; Hamano K
J Transl Med; 2017 Feb; 15(1):49. PubMed ID: 28235425
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
